A detailed history of Qube Research & Technologies LTD transactions in Pfizer Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 527,100 shares of PFE stock, worth $14.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
527,100
Previous 170,600 208.97%
Holding current value
$14.7 Million
Previous $4.91 Million 197.84%
% of portfolio
0.02%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $88.3 Million - $101 Million
3,411,743 Added 266.73%
4,690,841 $130 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $4.42 Million - $5.74 Million
169,012 Added 15.23%
1,279,098 $36.8 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $11.6 Million - $13.6 Million
362,717 Added 48.53%
1,110,086 $36.8 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $25.7 Million - $29.7 Million
-711,273 Reduced 48.76%
747,369 $27.4 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $55 Million - $71.6 Million
1,396,976 Added 2265.39%
1,458,642 $59.5 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $40.2 Million - $52.5 Million
-964,039 Reduced 93.99%
61,666 $3.16 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $44.9 Million - $54.8 Million
1,025,705 New
1,025,705 $44.9 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $57.1 Million - $67.7 Million
-1,227,560 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $49.5 Million - $61.4 Million
1,083,046 Added 749.44%
1,227,560 $63.6 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $23.8 Million - $35.3 Million
-576,163 Reduced 79.95%
144,514 $8.53 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $15.2 Million - $19.6 Million
387,877 Added 116.55%
720,677 $31 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $5.88 Million - $6.66 Million
163,692 Added 96.8%
332,800 $13 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $35 Million - $39.5 Million
-1,046,035 Reduced 86.08%
169,108 $6.13 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $28.8 Million - $36.7 Million
861,156 Added 243.27%
1,215,143 $44.7 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $8.22 Million - $9.64 Million
258,803 Added 271.9%
353,987 $13 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $2.87 Million - $3.48 Million
95,184 New
95,184 $3.11 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $739,351 - $1.06 Million
-27,353 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $900,460 - $1.02 Million
27,353 New
27,353 $1.07 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $2.14 Million - $2.78 Million
-65,915 Closed
0 $0
Q2 2019

Aug 02, 2019

SELL
$36.98 - $41.52 $4.23 Million - $4.75 Million
-114,520 Reduced 63.47%
65,915 $2.86 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $6.28 Million - $6.9 Million
167,498 Added 1294.72%
180,435 $7.66 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $4.5 Million - $5.13 Million
-117,042 Reduced 90.05%
12,937 $565,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $4.48 Million - $5.43 Million
129,979 New
129,979 $5.73 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $299,821 - $319,639
-9,091 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $290,093 - $336,548
9,091 New
9,091 $322,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.